Aardvark Therapeutics, Inc. (AARD)
NASDAQ · Healthcare
Aardvark Therapeutics, Inc. Total Liabilities 2024–2025
Aardvark Therapeutics, Inc. annual/quarterly total liabilities history from 2024 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Aardvark Therapeutics, Inc. total liabilities for the quarter ending December 31, 2025 were 10.5M, a 95.55% increase year-over-year.
- Aardvark Therapeutics, Inc. total liabilities for 2025 were 10.5M, a 95.55% increase from 2024.
- Aardvark Therapeutics, Inc. total liabilities for 2024 were 5.4M.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Aardvark Therapeutics, Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $11 |
| 2024 | $5 |
| Aardvark Therapeutics, Inc. Quarterly Total Liabilities (Millions of US $) | |
|---|---|
| 2025-12-31 | $11 |
| 2024-12-31 | $5 |
Aardvark Therapeutics, Inc. Total Liabilities — FAQ
Aardvark Therapeutics, Inc. (AARD) total liabilities over the last 2 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see AARD's total liabilities history?
The chart and table above show Aardvark Therapeutics, Inc.'s total liabilities by year and by quarter, including the growth rate.